Europe — EMA
Omjjara (Momelotinib)
Momelotinib, the active ingredient in Omjjara, is a drug presented as a oral tablet for oral use. It is being investigated for the treatment of myelofibrosis and related blood disorders in adults.
Request sourcing
What is Momelotinib?
Momelotinib, the active ingredient in Omjjara, is a drug presented as a oral tablet for oral use. It is being investigated for the treatment of myelofibrosis and related blood disorders in adults. GNH USA supplies Omjjara as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Omjjara as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Momelotinib used for?
Omjjara (momc ‑ ...)
- Myelofibrosis: ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - .... .... ....
What are the side effects of Momelotinib?
Common ....
What precautions apply to Momelotinib?
The ...
What does Momelotinib interact with?
The ...
